Skip to main content

Table 3 Post-treatment changes in IPSS

From: Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review

  No. of pts. (%) IPSS (mean ± SD)
Included patients 118 (100%) 11.2 ± 5.1
≥ 5-point increase at 1.5 months 70 (59%) 6.8 ± 3,3
≥ 5-point decrease after 1.5 months 45 (38%) 4.6 ± 2.1
  1. IPSS: International prostate symptom score, SD: Standard deviation.